Looking at life after the No Vote needs to look at all the parts that form Rap
The primary product is DX - it diagnoses Respiratory Diseases, is used for Telehealth, is needed for Triage and Monitoring of Respiatory conditions - this is what Rap is about using AI for health and hospitals, - it has huge potential.
Then we have Covid Detection that has the attention of Pfizer and also has high potential.
And let’s not forget Sleepcheck - it now has FDA approval and can accurately detect sleep apnoea
It is my thinking that we should sell either Sleepcheck or our Covid detection
Other people here would have a better idea of what we could get but companies like Resmed would sell a lot more machines with a cheap means of identifying sleep apnoea - I would think $20mil plus
This would give us the money to properly develop DX without the problem of take overs and capital raising.
Rap is to good to give away, - it does give a voice, vision,and analysis of sensory data utilising AI
- Forums
- ASX - By Stock
- RAP
- What to expect if Pfizer's takeover fails
What to expect if Pfizer's takeover fails, page-100
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)